CDC's Opioid Final Guideline Narrows Duration Of Use For Chronic Pain
This article was originally published in The Pink Sheet Daily
Three days of opioid use for acute pain 'will often be sufficient' and more than seven days 'will rarely be needed;' NEJM editorial by CDC officials emphasizes risks of opioid use.
You may also be interested in...
In unusual public hearing, Edwin Thompson, head of the US firm that contract manufactures Endo’s long-acting opioid, tells US FDA advisory committee that intranasal ‘liking’ study violated FDA requirements. Thompson has petitioned the agency to do away with need for human abuse liability studies entirely, asserting they are inherently flawed.
If Biden administration wants to nominate the acting commissioner, Vacancies Reform Act would dictate the timing. Woodcock can still get the nod and remain head of the agency during the confirmation process, just as Andrew von Eschenbach retained his acting title following his nomination in 2006.
President Biden’s picks to fill two commissioner posts may shift dynamics on pharmaceutical industry enforcement. Rohit Chopra’s nomination to Consumer Financial Protection Bureau removes strong critic of pharma mergers.